Skip to content

Doxorubicinhydrochlorid Teva® 2 mg/ml Konzentrat zur Herstellung einer Infusionslösung

DRUG2 trials

Sponsors

GPOH gGmbH, Takeda Development Center Americas Inc.

Conditions

Advanced Classical Hodgkin Lymphomaatypical teratoid/rhabdoid tumours (ATRT)